Correction: Yeh et al. Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates. Biomedicines 2021, 9, 1582
- PMID: 39857831
- PMCID: PMC11763060
- DOI: 10.3390/biomedicines13010188
Correction: Yeh et al. Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates. Biomedicines 2021, 9, 1582
Abstract
In the original publication [...].
Figures


Erratum for
-
Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates.Biomedicines. 2021 Oct 30;9(11):1582. doi: 10.3390/biomedicines9111582. Biomedicines. 2021. PMID: 34829812 Free PMC article.
References
-
- Yeh Y.-C., Lawal B., Hsiao M., Huang T.-H., Huang C.-Y.F. Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates. Biomedicines. 2021;9:1582. doi: 10.3390/biomedicines9111582. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources